Status | Study |
Withdrawn |
Study Name: Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis Condition: Trachoma Lymphatic Filariasis Date: 2013-07-15 Interventions: Drug: azithromycin Drug: ivermectin |
Recruiting |
Study Name: Mass Drug Administration for Lymphatic Filariasis and Onchocerciasis for Liberia Condition: Lymphatic Filariasis Onchocerciasis Date: 2013-07-12 Interventions: Drug: Annual versus Semiannual Albendazole plus Ivermectin Mass Drug Administration Annual or semiannual |
Completed |
Study Name: Disability and Quality of Life in Patients With Lymphatic Filariasis in Rural Southern India Condition: Lymphatic Filariasis Date: 2012-06-26 |
Completed |
Study Name: Exhaled NO Testing in Filariasis Condition: Filariasis Date: 2012-06-22 |
Active, not recruiting |
Study Name: Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis Condition: Lymphatic Filariasis Soil Transmitted Helminth Infections Date: 2012-04-11 Interventions: Drug: Albendazole and diethylcarbamazine Albendazole 400 mg plus diethylcarbamazine 6 mg/kg once yearly |
Terminated |
Study Name: Efficacy of Higher Albendazole and Ivermectin Doses on Wuchereria Bancrofti Microfilarial Clearance in Malawi Condition: Lymphatic Filariasis Date: 2010-09-30 Interventions: Drug: Albendazole 400mg and ivermectin 200mcg/kg |
Completed |
Study Name: Promoting Consistent Shoe Use Among Children At High Risk for Podoconiosis Condition: Podoconiosis Non-Filarial Elephantiasis Date: 2010-07-09 |
Completed |
Study Name: Effect of Albendazole Dose on Treatment of Lymphatic Filariasis Condition: Lymphatic Filariasis Date: 2007-08-02 Interventions: Drug: Albendazole Comparing 40 |
Completed |
Study Name: Medical Implications of Coinfection With Malaria and Filariasis Parasites Condition: Malaria Filariasis Date: 2007-05-09 |
Completed |
Study Name: Research for Elimination of Lymphatic Filariasis (ICIDR) Condition: Lymphatic Filariasis Date: 2006-11-30 |